0001417827-17-000001.txt : 20170214 0001417827-17-000001.hdr.sgml : 20170214 20170213175331 ACCESSION NUMBER: 0001417827-17-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170214 DATE AS OF CHANGE: 20170213 EFFECTIVENESS DATE: 20170214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Miragen Therapeutics, Inc. CENTRAL INDEX KEY: 0001417827 IRS NUMBER: 204362468 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-280608 FILM NUMBER: 17601146 BUSINESS ADDRESS: STREET 1: 6200 LOOKOUT ROAD #100 CITY: Boulder STATE: CO ZIP: 80301 BUSINESS PHONE: (303) 531-5952 MAIL ADDRESS: STREET 1: 6200 LOOKOUT ROAD #100 CITY: Boulder STATE: CO ZIP: 80301 FORMER COMPANY: FORMER CONFORMED NAME: Miragen Therapeutics Inc DATE OF NAME CHANGE: 20071107 D 1 primary_doc.xml X0707 D LIVE 0001417827 Miragen Therapeutics, Inc. 6200 LOOKOUT ROAD #100 Boulder CO COLORADO 80301 (303) 531-5952 DELAWARE 358th Shelf Corporation Miragen Therapeutics Inc Corporation true William S. Marshall 6200 Lookout Road #100 Boulder CO COLORADO 80301 Executive Officer Director Bruce L. Booth 6200 Lookout Road #100 Boulder CO COLORADO 80301 Director John W. Creecy 6200 Lookout Road Boulder CO COLORADO 80301 Director Thomas E. Hughes 6200 Lookout Road #100 Boulder CO COLORADO 80301 Director Kevin Koch 6200 Lookout Road #100 Boulder CO COLORADO 80301 Director Kyle A. Lefkoff 6200 Lookout Road #100 Boulder CO COLORADO 80301 Director Jason A Leverone 6200 Lookout Road #100 Boulder CO COLORADO 80301 Executive Officer Adam S Levy 6200 Lookout Road #100 Boulder CO COLORADO 80301 Executive Officer Paul D. Rubin 6200 Lookout Road #100 Boulder CO COLORADO 80301 Executive Officer Biotechnology Decline to Disclose 06b false 2017-02-13 false true false 0 Wedbush Securities Inc. 877 Wedbush Securities Inc. 877 1000 Wilshire Blvd. Los Angeles CA CALIFORNIA 90017 CA CALIFORNIA CO COLORADO MD MARYLAND MA MASSACHUSETTS NJ NEW JERSEY NY NEW YORK UT UTAH true 40703067 40703067 0 false 25 1199999 0 0 false Miragen Therapeutics, Inc. /s/ Jason A. Leverone Jason A. Leverone Chief Financial Officer 2017-02-13